Martek Biosciences Corporation

Martek is now a fullly-owned DSM subsidiary

DSM begins Martek integration

By Shane Starling

Royal DSM has kicked the integration of its new €800m wholly-owned subsidiary, Martek Biosciences Corporation, into life by establishing a special integration unit to manage the US-Dutch-Swiss deal.

DSM reports successful tender offer for Martek

DSM reports successful tender offer for Martek

By Mike Stones

Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...

Martek rejigs sales unit

Martek rejigs sales unit

Martek Biosciences Corporation, the US group which produces DHA and
EPA omega-3 ingredients, is to consolidate all its sales activities
related to products for the food and beverage industry in a bid to
streamline operations.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All